valaciclovir actavis 250
teva pharma (new zealand) limited - valaciclovir hydrochloride monohydrate 305.85mg equivalent to valaciclovir base 250 mg - film coated tablet - 250 mg - active: valaciclovir hydrochloride monohydrate 305.85mg equivalent to valaciclovir base 250 mg excipient: magnesium stearate microcrystalline cellulose opadry white y-5-7068 povidone - valaciclovir actavis is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.
vitamine b6 sterop 250 mg/2 ml inj. sol./or. sol. i.v./i.m. amp.
laboratoires sterop sa-nv - pyridoxine hydrochloride 250 mg/2 ml - solution for injection; oral solution - 250 mg/2 ml - pyridoxine hydrochloride 250 mg - pyridoxine (vit b6)
clarithromycine eg 250 mg film-coat. tabl.
eg sa-nv - clarithromycine 250 mg - film-coated tablet - 250 mg - clarithromycine 250 mg - clarithromycin
diamox 250 mg tabl.
amdipharm ltd. - acetazolamide 250 mg - tablet - 250 mg - acetazolamide 250 mg - acetazolamide
ceporex 250 mg film-coat. tabl.
intervet international b.v. - cefalexin 250 mg - film-coated tablet - 250 mg - cefalexin 250 mg - cefalexin - dog
metrobactin 250 mg tabl.
dechra regulatory b.v. - metronidazole 250 mg - tablet - 250 mg - metronidazole 250 mg - metronidazole; qp51aa01 metronidazole - dog; cat
metrocare 250 mg tabl.
ecuphar sa-nv - metronidazole 250 mg - tablet - 250 mg - metronidazole 250 mg - metronidazole - dog; cat
metrovis 250 mg tabl.
livisto int'l s.l. - metronidazole 250 mg - tablet - 250 mg - metronidazole 250 mg - metronidazole - dog; cat
metroclos 250 mg tabl.
vet-agro multi-trade company sp. z o.o. - metronidazole 250 mg - tablet - 250 mg - metronidazole 250 mg - metronidazole - cat; dog
recombinate 250 iu inj. sol. (pwdr. + solv.) i.v. vial
baxalta innovations gmbh - octocog alfa 250 iu/5 ml - powder and solvent for solution for injection - 250 iu/ 5 ml - octocog alfa 250 iu - coagulation factor viii